Part-time versus full-time occlusion therapy for treatment of amblyopia: A meta-analysis by Yazdani, N. et al.
 The University of Bradford Institutional 
Repository 
http://bradscholars.brad.ac.uk 
This work is made available online in accordance with publisher policies. Please refer to the 
repository record for this item and our Policy Document available from the repository home 
page for further information. 
To see the final version of this work please visit the publisher’s website. Access to the 
published online version may require a subscription. 
Link to publisher version: https://doi.org/10.1016/j.joco.2017.01.006  
Citation: Yazdani N, Sadeghi R, Momeni-Moghaddam H et al (2017) Part-time versus full-time 
occlusion therapy for treatment of amblyopia: A meta-analysis. Journal of Current 
Ophthalmology. 29(2): 76-84. 
Copyright statement: © 2017 The Authors. This is an Open Access article distributed under the 
Creative Commons CC-BY license. 
 
Available online at www.sciencedirect.comScienceDirect
Journal of Current Ophthalmology 29 (2017) 76e84
http://www.journals.elsevier.com/journal-of-current-ophthalmologyReview
Part-time versus full-time occlusion therapy for treatment of amblyopia:
A meta-analysis
Negareh Yazdani a,b, Ramin Sadeghi c, Hamed Momeni-Moghaddam a,b, Leili Zarifmahmoudi c,
Asieh Ehsaei a,b,*, Brendan T. Barrett d
a Refractive Errors Research Center, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
b Department of Optometry, Mashhad University of Medical Sciences, Mashhad, Iran
c Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
d School of Optometry and Vision Science, University of Bradford, Bradford, United Kingdom
Received 10 November 2016; revised 9 January 2017; accepted 29 January 2017
Available online 6 March 2017AbstractPurpose: To compare full-time occlusion (FTO) and part-time occlusion (PTO) therapy in the treatment of amblyopia, with the secondary aim of
evaluating the minimum number of hours of part-time patching required for maximal effect from occlusion.
Methods: A literature search was performed in PubMed, Scopus, Science Direct, Ovid, Web of Science and Cochrane library. Methodological
quality of the literature was evaluated according to the Oxford Center for Evidence Based Medicine and modified Newcastle-Ottawa scale.
Statistical analyses were performed using Comprehensive Meta-Analysis (version 2, Biostat Inc., USA).
Results: The present meta-analysis included six studies [three randomized controlled trials (RCTs) and three non-RCTs]. Pooled standardized
difference in the mean changes in the visual acuity was 0.337 [lower and upper limits: 0.009, 0.683] higher in the FTO as compared to the PTO
group; however, this difference was not statistically significant (P ¼ 0.056, Cochrane Q value ¼ 20.4 (P ¼ 0.001), I2 ¼ 75.49%). Egger's
regression intercept was 5.46 (P ¼ 0.04). The pooled standardized difference in means of visual acuity changes was 1.097 [lower and upper
limits: 0.68, 1.513] higher in the FTO arm (P < 0.001), and 0.7 [lower and upper limits: 0.315, 1.085] higher in the PTO arm (P < 0.001)
compared to PTO less than two hours.
Conclusions: This meta-analysis shows no statistically significant difference between PTO and FTO in treatment of amblyopia. However, our
results suggest that the minimum effective PTO duration, to observe maximal improvement in visual acuity is six hours per day.
Copyright © 2017, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Amblyopia is a relatively common disorder, affecting
1e4% of the general population.1e4 This condition features a
unilateral or, less commonly, a bilateral loss of vision caused
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).critical period of visual development (the first 8e10 years of
life). It represents visual loss at a cortical level where infor-
mation first interacts between the two eyes. If not treated
during the critical period, amblyopia can cause lifetime sig-
nificant visual impairment.5 Although improvements are
possible in adults with proper treatment, early detection and
treatment still offer the best outcome.6,7
The basic pathophysiologic mechanisms of amblyopia are
abnormal binocular interaction and pattern vision deprivation.
Amblyopia can be classified based on the underlying cause;
strabismus, refractive error (anisometropia or bilateral highosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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anisometropic amblyopia commonly co-exist.9
In amblyopia therapy, the first step is correction of the
refractive error and constant use of spectacles and/or contact
lenses until no further improvement in visual acuity is ob-
tained.10 The next step is often occlusion therapy in order to
force reliance upon the weaker eye by patching the dominant
eye. Occlusion therapy and appropriate refractive correction
remain the mainstay of treatment since the 18th century, and
while newer approaches to treatment are emerging, occlusion
retains its central place in amblyopia treatment in most clinical
settings.11 Occlusion variables are classified according to the
area of visual field occluded (total or full and partial or
sectorial e.g. bi-nasal patch for promotion of alternate fixa-
tion), effect on light transmission (opaque or non-transmitting
for light and form and attenuating or partial light transmission)
and wearing time.12
Amongst clinicians, there are different opinions about the
appropriate duration of occlusion therapy for maximum
treatment effect, ranging from short periods of occlusion [part-
time occlusion (PTO)] to full-time occlusion (FTO) for the
treatment of amblyopia. Some clinicians are proponents of
FTO, and believe that appropriately-monitored patients treated
with FTO can have excellent outcomes.13,14 However, sup-
porters of PTO, by contrast, feel that less patching time is not
inferior to FTO.15 Occlusion amblyopia, or the development of
amblyopia in the originally better-seeing, patched eye, is a risk
commonly cited by opponents of FTO. Although the incidence
of occlusion amblyopia in children treated with FTO is
admittedly significant (19.3%,16 25.8%,14), it is almost always
reversible.12 Furthermore, after cessation of treatment, the
final interocular difference in visual acuity was actually less in
children with a history of occlusion amblyopia, suggesting that
occlusion amblyopia can herald a better visual potential in the
initially amblyopic eye.14,16
Some studies suggest that FTO results in better improvement
in visual acuity of amblyopic eyes than does PTO.15,17,18 One
retrospective review in a small sample size (n ¼ 45), demon-
strated a trend toward better visual outcome and a more rapid
improvement in patients treated with FTO compared to those
treated with PTO (<6 h).13 However, there is continuing con-
troversy regarding the number of hours of patching per day that
should be prescribed for amblyopia, ranging from less than 2 hrs
a day,15,18 or between 2 and 6 hrs a day (part-time occlu-
sion)15,17 to more than 10 hrs a day, 7 days a week (i.e. FTO).17
The primary objective of this systematic review and meta-
analysis was to investigate the efficacy of full-time versus
PTO therapy in the process of rehabilitation of amblyopic
patients.
MethodsSearch strategy and inclusion criteriaFor considering studies for this systematic review, we
included randomized controlled trials (RCTs) and observa-
tional, peer-reviewed publications that compared the effects oftwo patching regimens: FTO (more than 10 hrs a day or all
waking hours) and PTO (6 hrs or less). Participants in these
trials were children diagnosed with amblyopia (strabismic,
anisometropic, strabismic & anisometropic), had visual acuity
in the weaker eye between 0.3 and 1.3 logMAR, visual acuity
in the sound eye of 0.3 logMAR or better, no previous
amblyopia therapy, no ocular pathology, no prior surgery.
Additionally, where anisometropia was diagnosed, it was more
than 0.5 diopter difference in the spherical equivalent refrac-
tion, and when strabismus was diagnosed, it was constant not
intermittent. There was no restriction for time of follow-up as
different studies had different time point for follow-up. Studies
with combination therapies, those considering FTO or PTO as
a treatment option alone, using atropine as a penalization
method, limited to only one type of amblyopia, or those with
any associated active treatment options were excluded from
this meta-analysis.
For identification of studies, we searched PubMed, Scopus,
Science Direct, Ovid, Web of Science and Cochrane library
from their inception to March 2016. Search terms were “part-
time”, “full-time”, “patching”, “occlusion”, “amblyopia” or
“therapy”. In addition, reference lists of relevant articles were
searched for additional trials and we used the Science Citation
Index to search for articles that cited the included studies. No
language limit was exerted on the search strategy. Unpublished
papers were not included.
We used Der-Simonian and Laird method or random effects
model in order to pool the studies. In this method, between
study variability is taken into account for weighting and is
more suitable for heterogeneous studies.19
Two authors (NY & AE) checked the titles and abstracts
obtained by the searches to determine whether they met the
inclusion criteria (mentioned above) for this review.Statistical analysisFor each study, the mean difference in visual acuity
recorded in logMAR notation was determined for the PTO and
FTO groups. To pool the effect sizes across studies, a random
effects model was used. Heterogeneity was evaluated by the
Cochrane Q test (the significance level was considered to be
0.05.) and I2 index.20 Publication bias was evaluated graphi-
cally by funnel plots and statistically by Egger's regression
intercept method.21
The quality of the RCTs was evaluated by the Oxford
Center for Evidence Based Medicine checklist for RCTs.22
Observational studies were checked by the modified
Newcastle-Ottawa scale for observational studies.23 Sub-group
analyses according to the study design (RCT vs. non-RCT)
and duration of part-time patching were also performed. All
statistical analyses were performed using Comprehensive
Meta-Analysis (version 2, Biostat Inc., USA).
Results
Fig. 1 shows the PRISMA flowchart for this review.
Overall, six studies were included in this systematic review.
Fig. 1. PRISMA flowchart of studies evaluated in detail. FTO: Full-time occlusion, PTO: Part-time Occlusion.
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were observational, non-randomized trials. Table 1 shows the
characteristics of the six studies. Tables 2 and 3 show the
quality assessment of the included studies.
Pooled standardized difference in means of changes in the
visual acuity was 0.337 [lower and upper limits: 0.009,
0.683] higher in the FTO as compared to the PTO group
(P ¼ 0.056, Cochrane Q value ¼ 20.4 (P ¼ 0.001),
I2 ¼ 75.49%), although this difference did not reach statisticalTable 1
Characteristics of the included studies.
Authors Study
design
Region Age
(years)
Type of
amblyopia
FTO (>10 h)
duration
sample
size
PTO (2
duration
sample
size
Stewart
et al (2007)24
RCT United
Kingdom
3e8 AA, SA,
MA
12 h
n ¼ 40
6 h
n ¼ 40
Arikan
et al (2005)15
nRCT Turkey 3e12 AA, SA,
MA
All waking
hours n ¼ 39
2e6 h
n ¼ 70
PEDIG (2003a)17 RCT United
States
<7 AA, SA,
MA
All waking
hours n ¼ 90
6 h
n ¼ 85
PEDIG (2003b)34 nRCT United
States
3e7 AA, SA,
MA
>10 h
n ¼ 55
6 h
n ¼ 91
Hug (2004)13 nRCT United
States
3e7 AA, SA All waking
hours n ¼ 21
<6 h
n ¼ 24
Singh
et al (2008)4
RCT India 7e12 AA, SA,
MA
All waking
hours n ¼ 25
6 h
n ¼ 25
RCT: Randomized controlled trial, AA: Anisometropic amblyopia, SA: Strabismic
Occlusion, W: Weeks, Y: Years, hrs: Hours, M: Months, PEDIG: Pediatric Eye Dsignificance. Figs. 2 and 3 show the forest and funnel plots of
this main analysis. Egger's regression intercept was 5.46,
P ¼ 0.04.
Fig. 2A shows that in two of the non-RCT studies, the FTO
was significantly better than PTO (P ¼ 0.001 and P < 0.001).
However, considering all non-RCT studies, this difference did
not reach statistical significance (P ¼ 0.074). Fig. 2A also
illustrates that the FTO was not statistically different from
PTO occlusion (P ¼ 0.666) in RCT design studies.e6 h) PTO (<2 h)
duration
sample size
Follow-up Mean improvement
in visual acuity in
lines from baseline
Conclusion
e Every 2 W FTO:2.4
PTO:2.6
PTO and FTO
prescribed occlusion
results in similar
visual outcome.
Less than
1 h n ¼ 19
6 M
10 Y
FTO:5.8
PTO (2e6 h): 3.5
PTO (<2 h): 0.19
The amount of
improvement in
visual acuity was
significantly higher
in FTO group.
e 5 W
4 M
FTO:4.7
PTO:4.8
Visual acuity in
the amblyopic
eye improved a
similar amount.
e 5 W
16 W
6 M
FTO:3.3
PTO:3.1
At 6 months,
improvement
appears to be
similar with PTO
vs FTO.
e 1e3 M FTO:3.5
PTO:2.5
FTO was more
effective than PTO.
Less than 2 h
n ¼ 25
18 W FTO:3.6
PTO (2e6 h): 3.00
PTO (<2 h): 0.17
PTO (2e6) and
FTO were more
effective than two
hours occlusion
therapy.
amblyopia, MA: Mixed amblyopia, FTO: Full-time Occlusion, PTO: Part-time
isease Investigator Group.
Table 2
Quality assessment of the randomized clinical studies.
Article Randomization method Similarity
of the groups
Aside
from the allocated
treatment, were groups
treated equally?
Intention
to treat? Lost
to follow-up?
Objective
measures?
Blinding?
PEDIG (2003a)17 Permuted-blocks design
of varying block sizes, with a
separate sequence of
computer-generated random
numbers for each clinical site.
Yes Yes Yes
18/157
Yes
NA
Stewart (2007)24 Using a random number
generator in the statistical
package “R” (www.r-project.org/),
stratified, but not blocked, by
type of amblyopia and implemented
by means of a concealed typed allocation list.
Yes Yes Yes
10/90
Yes
NA
Singh et al (2008)4 Computer-generated random numbers Yes Yes NA
NA
Yes
NA
NA: Not Available.
PEDIG: Pediatric Eye Disease Investigator Group.
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and all waking hours per day) was not statistically different
from PTO (P ¼ 0.257).
Fig. 2C shows that FTO and PTO of 2e6 h were signifi-
cantly different (P ¼ 0.001), however, the difference between
FTO and PTO equal to 6 h did not reach statistical significance
(P ¼ 0.684).
Table 3
Quality assessment of observational studies.
Article Inclusion criteria
PEDIG (2003b)34  Sufficient maturity to complete the study's visu
acuity testing protocol
 Visual acuity in the amblyopic eye between 20
and 20/100 inclusive
 Inter-eye acuity difference 0.3 LogMAR
 The presence or a history of an amblyogenic
factor meeting study-specified criteria for strab
or anisometropia,
 the wearing of optimal spectacle correction for
minimum of 4 weeks at the time of enrollment
 No more than 2 months of amblyopia treatment
previous 2 years
Arikan et al (2005)15  Patients with strabismic, anisometropic and mi
amblyopia
 No previous occlusion therapy
 Complete follow up for at least 6 month
 Patients with esotropia deviation
Hug (2004)13  Patients with diagnosis of amblyopia
 Patients with age range of 3e7 years
 No organic amblyopia
 Completing the follow up
NA: Not Available.
PEDIG: Pediatric Eye Disease Investigator Group.Subgroup analyses according to the study design and
duration of occlusion can be found in Table 4.
Two studies evaluated PTO of less than two hours
compared to the PTO of 2e6 hrs and FTO (>10 hrs/day)
methods.15,18 Pooled standardized difference in means of vi-
sual acuity changes was 1.097 [lower and upper limits: 0.68,
1.513] higher in the FTO arm (P ¼ 0.0000002), and 0.7 [lowerComparability Outcome
 Objective
 Lost to follow-up
 Treatment duration
al
/40
ismus
a
,
in the
NA  Yes
 NA
 6 months
xed The mean age at
start of treatment
was significantly
higher for anisometropic
amblyopia
 Yes
 51/128
 Mean:3 years
and 2 months
NA  Yes
 NA
 For the full-time
occlusion group
was 6 weeks
(range: 1e9 weeks).
 For the part-time
group was 26 weeks
(range: 8e58 weeks).
Fig. 2. (A): Random-effect meta-analysis according to study design. (B): Random effects meta-analysis according to the duration of occlusion in the full-time
group (>10 hrs and all waking hours). (C): Random effects meta-analysis according to the duration of part-time occlusion. (D): Random effects meta-analysis
according to less than two hours of occlusion (minimal) analysis. PEDIG: Pediatric Eye Disease Investigator Group.
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Fig. 2. (continued).
Fig. 3. Funnel plot of standard error by standard difference in means. PEDIG: Pediatric Eye Disease Investigator Group.
Table 4
Subgroup analysis based on the study design and duration of patching.
Variables RCTs Non-RCTs FTO PTO
More than 10 hrs All waking hrs Equal to 6 hrs Less than 6 hrs
Pooled Standardized difference in: means
[lower and upper limits]
P value [reference]
0.105
[0.334, 0.544]
0.63924
0.687
[0.284, 1.089]
0.00115
0.105
[0.334, 0.544]
0.63924
0.687
[0.284, 1.089]
0.00115
0.105
[0.334, 0.544]
0.63924
0.687
[0.284, 1.089]
0.00115
0.043
[0.339, 0.254]
0.77817
0.015
[0.320, 0.350]
0.93034
0.015
[0.320, 0.350]
0.93034
0.043
[0.339, 0.254]
0.77817
0.043
[0.339, 0.254]
0.77817
1.281
[0.638, 1.923]
<0.00113
0.286
[0.272, 0.843]
0.3154
1.281
[0.638, 1.923]
<0.00113
1.281
[0.638, 1.923]
<0.00113
0.015
[0.320, 0.350]
0.93034
0.286
[0.272, 0.843]
0.3154
0.286
[0.272, 0.843]
0.3154
P value indicates the significance level of difference between modalities of occlusion therapy for each study. FTO: Full-time Occlusion, PTO: Part-time Occlusion,
RCTs: Randomized control trials. hrs: Hours. Numbers in superscript formats refer to the reference (see bibliography).
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(P ¼ 0.0003) as compared to PTO less than two hours. Fig. 2D
shows that both FTO and PTO (2e6 hrs) were statistically
different compared to PTO (less than 2 hrs) (P < 0.001).
Discussion
This systematic review shows no statistically significant
difference between PTO and FTO in treatment of amblyopia,
although the mean improvement in visual acuity was clinically
higher in FTO compared to PTO group (Fig. 2A). However,
according to the results presented in this meta-analysis, the
minimum effective PTO to observe maximal improvement in
visual acuity is six hours per day (Fig. 2C and D).
According to the quality assessment of this meta-analysis,
all included studies had very high heterogeneity (Fig. 3).
This systematic review found that in RCT studies there was
no significant difference between FTO and PTO. However,
in observational studies, the therapeutic effect was statisti-
cally higher in FTO group compared to PTO group. Hence,
the study design appears to influence the results, and the
level of evidence plays an important role in heterogeneity of
studies.
Studies differed significantly with respect to the duration of
occlusion in PTO group. Consistent with previous find-
ings,13,15 results presented in this meta-analysis illustrated that
PTO groups with 2e6 hrs occlusion showed lower therapeutic
effect in comparison with FTO group. PTO of less than two
hours appeared to be much less effective than FTO. However,
there was no significant difference in visual acuity between
PTO of 6 hrs and FTO. In addition, the duration of occlusion
in FTO group (>10 hrs or all waking hours) did not have a
significant effect on the pooled effect size.
The success of any treatment modality depends on its
acceptability to the patient and, in the case of amblyopia, also
to the parents or other principal caregivers. This issue is
certainly true about the occlusion therapy for amblyopia. One
important factor associated with successful occlusion therapy
is the length of the treatment course as this is an important
factor in compliance with treatment. Aside from the duration
of the treatment course, another important aspect relating to
compliance is the number of occlusion hours per day.
Considerable variation in compliance has been reported with
change of the occlusion dose, with higher doses of occlusion
being associated with more variation in compliance.17,24,25
The nature of the interaction between daily dose and overall
treatment duration has been studied; for example, one study
found that most children achieved their best visual acuity with
150e250 hrs cumulative dose.26
Monitoring the occlusion dose is an important factor when
judging the compliance with prescribed treatment. This is not
something which is practical in clinical settings. Studies on the
different types of amblyopia (anisometropic, strabismic and
mixed) using objective occlusion dose monitoring have shown
that the actual amount of occlusion undertaken is often
considerably less than the amount prescribed.27e29 These
findings highlight one advantage of prescribing FTO, becauseof the chance that the patient has occluded the sound eye for at
least several hours.
Different criteria for a successful therapeutic outcome have
been used in the different studies, for example achieving a
specific level of visual acuity, including best corrected visual
acuity of at least 20/70 (6/18),30 20/80 (6/24),31 20/25 (6/
7.5),32 and 20/50 (6/15).33 When such different criteria are
used, it becomes very difficult to compare the efficacy of
different treatment modalities. In order to identify the opti-
mum treatment regimen, the Pediatric Eye Disease Investi-
gator Group (PEDIG) designed multi-center randomized
clinical trials on children younger than 7 years old with either
strabismic or anisometropic amblyopia.17,25,34 They stated
their criterion for success as visual acuity of at least 20/32 or a
gain of 3þ lines of visual acuity in the amblyopic eye at 4
months after initiation of therapy. Their purpose was to
compare prescribed patching regimens of 2 hrs daily PTO to
6 hrs daily PTO in patients with moderate amblyopia,25 and
prescribed patching regimens of 6 hrs daily PTO to FTO in
those with severe amblyopia.17 Moderate and severe ambly-
opia were defined as visual acuity 20/40e20/80 and 20/
100e20/400, respectively.17,25 In the moderate amblyopia
study, similar visual acuity outcomes were reported between
the two PTO regimens of 2 and 6 hrs daily. Specifically, they
found an equal percentage (62%) of patients in both groups
who were ‘successfully’ treated at 4 months after initiation of
therapy. Notably, however, there were more patients with vi-
sual acuity of 20/25 or better in the prescribed 6-hrs PTO
group at the time of last follow-up.25 Comparing FTO and
PTO in moderate amblyopia, they have also illustrated that
increasing the occlusion time is more valuable (e.g. mean line
change in PTO (6 hrs) and FTO: 3.1 and 3.3 lines, respec-
tively).24 Thus, if the treatment goal is to obtain better visual
acuity following treatment, it may be that longer daily doses of
occlusion provide greater chances of success. If so, this would
be consistent with the results of the current review and meta-
analysis.
Visual acuity outcomes were reported between patients
prescribed 6 hrs daily PTO and those prescribed FTO in the
severe amblyopia study.17 There was a slight improvement in
visual acuity in the patched eye in the PTO group but not in
the FTO group, (e.g. mean line change in PTO (6 hrs) and
FTO: 0.5 and 0.1, respectively); however, this difference was
attributed by the authors to a learning effect, and felt to be
unlikely due to occlusion amblyopia. This effect was transient
and resolved on further follow-up. There were no differences
between the two groups in terms of parent-reported ease of
compliance or social stigma. This led to the PEDIG recom-
mendation that patients with severe amblyopia should be
prescribed 6 hrs of daily PTO.17 Because these studies
compared prescribed patching duration and not what was
actually undertaken, it is possible that the patients prescribed
FTO actually wore the patch significantly less than full-time,
with the result that the difference in amount of occlusion
undertaken may not be as large as conceived by the designers
of the study. If the latter is true, it would account for the
similarity in treatment outcome of the PTO (6 hrs) and the
83N. Yazdani et al. / Journal of Current Ophthalmology 29 (2017) 76e84FTO groups.17 This study suggests that PTO (6 hrs) is just as
beneficial as FTO. FTO carries with a number of disadvan-
tages including the fact that vision may be extremely poor in
the affected eye making it very difficult to pursue normal
living practices. Also, there is the possibility of occlusion
amblyopia of the sound eye14,16 and a greater likelihood that
the child will experience negative psychosocial emotions,35
for example as a result of bullying at school, because the
patching cannot only take place at home.36 Since PTO (6 hrs)
appears to be just as effective as FTO, many of the disad-
vantages of FTO can be avoided it seems.
Our review suggests that PTO of 6 hrs per day is the
minimum occlusion duration consistent with maximal treat-
ment effect. Six hours per day still represents a considerable
portion of a child's day. There has been much recent research
interest in alternative (i.e. non atropine- or occlusion-based)
approaches to treating amblyopia. In particular, recent tech-
nological approaches indicate similar treatment effects for
active treatment of amblyopia compared to the occlusion.37e39
Notably, these treatment effects seem to accrue in much
shorter durations. The methods being examined include use of
the perceptual learning technique, in combination with
dichoptic presentation of video games on a computer or
electronic tablet. However, these newer approaches have not
yet become part of standard clinical treatment of amblyopes,
even in the developed world and, because of their greater
(compared to occlusion therapy) financial cost, it is unlikely
they will be in widespread use anytime soon. In the meantime,
occlusion therapy remains more affordable and more feasible
option for most countries.
Finally, this systematic review of literature shows that PTO
and FTO have the same effect on treatment of amblyopia.
However, according to the results presented in this meta-
analysis, the minimum effective time to observe maximal
improvement in visual acuity is six hours of PTO per day.
This study has some limitations. The studies included eyes
with different inclusion criteria and variable length of follow-
up. Therefore, any conclusion is limited by the characteristics
of the studies. The only method in order to avoid publication
bias is searching a broad number of databases to locate all
possible studies. We did our best to increase the sensitivity of
our search strategy. However, publication bias is a major
concern in all systematic reviews and cannot be avoided
altogether. Citation bias is always a concern in systematic
reviews. However, we only used citation analysis as an adjunct
to the main search strategy.
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